Citation Impact
Citing Papers
COVID-19 and liver disease: mechanistic and clinical perspectives
2021
Microbiota in health and diseases
2022 Standout
Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism
2017
Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?
2002
Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States
2020
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
2009
A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis
2008
Liver transplantation and non-alcoholic fatty liver disease
2014
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
2009
Risk factors and prevalence of liver disease in review of 2557 routine liver biopsies performed during bariatric surgery
2019
Incidence and natural course of fatty liver in the general population: The Dionysos study
2007
Metformin in non-alcoholic fatty liver disease: A systematic review and meta-analysis
2012
Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis and treatment
2008
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Effect of Bariatric Surgery on Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-Analysis
2008
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Interaction between periodontitis and liver diseases
2016
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
2022
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
2011 Standout
Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
2008
Clinicopathological study of nonalcoholic fatty liver disease in Japan: the risk factors for fibrosis
2007
Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests
2008
Non-Alcoholic Fatty Liver Disease in Liver Transplant Recipients: Another Story of “Seed and Soil”
2009
Non-alcoholic fatty liver disease and liver transplantation
2016
Global burden of liver disease: 2023 update
2023 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
2020
Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures
2006
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
2021
Non‐alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C‐reactive protein in Hispanics
2008
Hepatocellular carcinoma
2022 Standout
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
2007
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
2007
Klebsiella pneumoniae: Going on the Offense with a Strong Defense
2016 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Therapeutic Role of Interleukin 22 in Experimental Intra-abdominal Klebsiella pneumoniae Infection in Mice
2016
Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up
2014 Standout
Fatty Liver
2007
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States
2015
Surgery for weight loss in adults
2014 Standout
Eight‐Fold Increase in Dietary Supplement–Related Liver Failure Leading to Transplant Waitlisting Over the Last Quarter Century in the United States
2021
Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data
2020
Works of Iris Liou being referenced
Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit
2015
Toward consensus reporting of radiation-induced liver toxicity in the treatment of primary liver malignancies: Defining clinically relevant endpoints
2017
Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit
2016
Comprehensive Care of Patients with Chronic Liver Disease
2015
Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B
2018
Natural history of nonalcoholic steatohepatitis.
2006
625 Development and Pilot of a Checklist for Management of Acute Liver Failure in the Intensive Care Unit
2013
Two‐year outcomes in initial survivors with acute liver failure: results from a prospective, multicentre study
2014